(Q51812729)

English

External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients.

scientific article published on 29 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

External validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology among Japanese patients. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

0 references

author name string

Takashi Imamoto

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Hiroyoshi Suzuki

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Takanobu Utsumi

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Makoto Takano

4

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Takahito Suyama

5

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Koji Kawamura

6

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Naoto Kamiya

7

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Yukio Naya

8

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Takeshi Ueda

9

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Tomohiko Ichikawa

10

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

language of work or name

0 references

publication date

29 August 2009

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

76

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

404-410

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Prostate biopsy grading errors: a sampling problem?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Patterns of prostate cancer biopsy grading: trends and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Prostate biopsy volume indices do not predict for significant Gleason upgrading

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

The role of testosterone in the pathogenesis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.05.084

7 January 2021

Identifiers

10.1016/J.UROLOGY.2009.05.084

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/19716590

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51812729&oldid=1368738394"